Add like
Add dislike
Add to saved papers

Comparison of transperitoneal and retroperitoneal partial nephrectomy with single port robot.

Journal of Endourology 2023 Februrary 19
PURPOSE: To investigate the efficacy and safety of single port robotic transperitoneal (TP) and retroperitoneal (RP) partial nephrectomy.

MATERIALS AND METHODS: From September 2021 to June 2022, 30 sequential cases of partial nephrectomy performed after a single port (SP) robot was introduced to our hospital were retrospectively analyzed. All patients were diagnosed with T1 renal cell carcinoma and operated by a single expert in conventional robot with a da Vinci SP platform.

RESULTS: A total of 30 patients underwent SP robotic partial nephrectomy, including 16 (53.33%) by TP and 14 (47.67%) by RP. Body mass index was slightly higher in the TP group (25.37 vs. 23.53, p-value = 0.040). Other demographic characteristics were not significantly different between the two groups. There was no statistically significant difference in ischemic time (727.41 ± 561.18 sec for TP and 698.56 ± 299.23 sec for RP, p-value = 0.812) or console time (67.97 ± 24.06 min for TP and 69.71 ± 28.66 min for RP, p-value = 0.724). There was no statistically significant difference in perioperative or pathological outcome either. Renal function calculated from DTPA was 103.33 ml/min/1.73m2 for TP and 101.33 ml/min/1.73m2 for RP (p-value = 0.214) postoperatively. It was 90.36 ml/min/1.73m2 for TP and 87.74 ml/min/1.73m2 for RP (p-value = 0.592) at 90 days after surgery.

CONCLUSION: SP robot partial nephrectomy can be performed effectively and safely regardless of the approach. Both TP and RP approaches offer similar perioperative and postoperative outcomes for T1 RCC.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app